Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Operating Leases (2019 - 2025)

BioCorRx's Operating Leases history spans 7 years, with the latest figure at $127757.0 for Q3 2025.

  • For Q3 2025, Operating Leases fell 38.79% year-over-year to $127757.0; the TTM value through Sep 2025 reached $127757.0, down 38.79%, while the annual FY2024 figure was $159127.0, 1353.88% up from the prior year.
  • Operating Leases for Q3 2025 was $127757.0 at BioCorRx, down from $179555.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $516132.0 in Q1 2021 and bottomed at $10945.0 in Q4 2023.
  • The 5-year median for Operating Leases is $189468.0 (2025), against an average of $235343.7.
  • The largest annual shift saw Operating Leases plummeted 93.96% in 2023 before it soared 1353.88% in 2024.
  • A 5-year view of Operating Leases shows it stood at $315672.0 in 2021, then tumbled by 42.56% to $181328.0 in 2022, then tumbled by 93.96% to $10945.0 in 2023, then skyrocketed by 1353.88% to $159127.0 in 2024, then dropped by 19.71% to $127757.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Operating Leases are $127757.0 (Q3 2025), $179555.0 (Q2 2025), and $189468.0 (Q1 2025).